Skip to content
Tenfell
Awarded contract
Published 18 Dec 2025

NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products

NHS England · London

Key facts

Awarded
11 Dec 2025
Contract starts
01 Mar 2026
Contract ends
29 Feb 2028
Procedure
Open procedure (framework)
Buyer type
Central government

Awarded to 7 suppliers

SupplierValue
Pfizer Ltd—
Viatris UK Healthcare Ltd—
Aventis Pharma Ltd T/A Sanofi—
ROVI Biotech Ltd—
Techdow Pharma England Ltd—
NORTHUMBRIA PHARMA LTD—
Venipharm LTD—

Description

NHS National Proprietary Pharmaceuticals – Low Molecular Weight Heparins and Fondaparinux Products – CM/PHR/25/5732 Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.